Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Why AstraZeneca plc may still not be cheap enough to beat this upstart

| Roland Head

Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative.

Read more »

Investing Articles

Should you invest in pills or joints?

| G A Chester

Which of these stocks should be on your shopping list today?

Read more »

Investing Articles

2 firms to hold until you retire and beyond

| Kevin Godbold

Brexit looks like a sideshow for these enduring businesses.

Read more »

Investing Articles

These FTSE 100 stocks sank in October. Time to stock up?

| Royston Wild

Royston Wild runs the rule over two recent FTSE 100 (INDEXFTSE: UKX) losers.

Read more »

Investing Articles

The Good, the Bad and the Ugly of pharma stocks

| Bilaal Mohamed

Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector.

Read more »

Investing Articles

Can these 2 stocks deliver healthy dividends forever?

| Harvey Jones

A dividend stock isn't just for today, it should deliver the goods year after year after year, says Harvey Jones.

Read more »

Investing Articles

Should you buy this stock after it reports a 27% rise in revenue?

| Peter Stephens

Is this company set to soar after positive results?

Read more »

Investing Articles

Forget short-term pain! Buy these FTSE 100 stars for long-term gain

| Royston Wild

Royston Wild looks at two brilliant FTSE 100 (INDEXFTSE: UKX) stocks for long-term investors.

Read more »

Investing Articles

These FTSE 100 beauties are just too cheap to miss!

| Royston Wild

Royston Wild reveals two FTSE 100 (INDEXFTSE: UKX) firecrackers trading far, far too cheaply.

Read more »

Investing Articles

These dividend stocks won’t yield 4%+ forever

| Peter Stephens

Getting a 4%+ yield from these shares beats savings accounts, but may not be available for much longer.

Read more »

Investing Articles

These two FTSE 100 dividends stars still look cheap

| Rupert Hargreaves

These two FTSE 100 (INDEXFTSE: UKX) firms look like safe dividend champions but still appear to be undervalued.

Read more »

Investing Articles

Do these 3 low yielders offer high growth prospects?

| Harvey Jones

A sky-high yield isn't everything these days, is it? Harvey Jones investigates.

Read more »